Serratia Marcescens Bacteria: Infections, and Prevention

Serratia marcescens is an opportunistic bacterium found widely in soil, water, and household surfaces that causes infections mainly in people whose immune defenses are already compromised. Healthy adults rarely get sick from it, but in hospitals, particularly intensive care units and neonatal wards, it can trigger outbreaks of bloodstream infections, pneumonia, urinary tract infections, and meningitis that carry meaningful mortality rates. The organism is also the culprit behind the pink or reddish slime you sometimes find on shower curtains, toilet bowls, and tile grout, a cosmetic nuisance in homes but a red flag for contamination in clinical settings.

What Makes This Bacterium Distinctive

The most recognizable trait of S. marcescens is prodigiosin, a deep red pigment it produces under the right conditions. Prodigiosin production is highest at temperatures around 22–30 °C and drops sharply at human body temperature (37 °C), which is why the bacterium often looks colorless in clinical cultures grown at body temperature but stains bathroom fixtures pink at room temperature.¹ This temperature-dependent switch is controlled at the genetic level by transcription factors that dial down pigment genes in warmer environments. Maximum pigment output in laboratory conditions has been achieved at 22 °C under alkaline conditions.²

Beyond its visual calling card, S. marcescens carries a toolkit of virulence factors: enzymes that break down tissue, molecules that scavenge iron from the host, and hemolysins that damage red blood cells.³ These features help the bacterium establish itself once it gains a foothold in a vulnerable host. It also forms biofilms, sticky microbial communities that adhere to surfaces and resist both the immune system and cleaning agents. Researchers have found that S. marcescens uses different adhesion strategies for living tissue versus plastic and metal surfaces; on nonliving surfaces like catheters and sink drains, a chemical signaling system called quorum sensing coordinates biofilm formation, while on human cells the bacterium relies on hair-like appendages called fimbriae instead.⁴

Who Gets Infected and Where

S. marcescens is primarily a hospital-acquired problem. The patients most at risk tend to be elderly, heavily medicated, and connected to invasive equipment. In ICU populations, the typical infected patient is around 69 years old, about two-thirds are male, and the most common risk factors include mechanical ventilation, central venous catheters, recent surgery, and prolonged antibiotic courses.⁵ Hospital water systems, sinks, and medical equipment serve as reservoirs. Genomic analyses have confirmed genetic matches between bacteria found in ICU sinks and bacteria found in patients, supporting direct environment-to-patient transmission.

Outside of hospitals, intravenous drug use is a significant and often overlooked route. In one study of S. marcescens bloodstream infections, 42% of patients were IV drug users, who tended to be much younger (median age 40 versus 71 for non-users) and were far more likely to carry hepatitis C. The most serious complications in that group were endocarditis and bone infections.⁶ Recurrent heart-valve infections have been documented in people who continue injecting drugs after initial treatment, sometimes returning within months with the same organism on a replacement valve.⁷

The Special Danger to Newborns

Neonatal intensive care units are uniquely vulnerable to S. marcescens outbreaks. Premature infants have immature immune systems, thin skin, and often require invasive lines and tubes that give bacteria a direct pathway into the body. In newborns, S. marcescens can cause a wide range of problems: eye infections, urinary tract infections, pneumonia, surgical wound infections, bloodstream infections, and meningitis. The bloodstream is the most common site, followed by the lungs and gastrointestinal tract. Strains involved in neonatal outbreaks are frequently multi-drug resistant.⁸

One NICU outbreak investigation found that affected infants had an average gestational age of just 27 weeks, were predominantly male, and developed infections at an average of 24 days after birth. Six of eleven infants were treated for conjunctivitis and one for bloodstream infection.⁹ The bacterium is considered an environmental organism that gets introduced and spread through contaminated hands, equipment, or ward surfaces. Whole-genome sequencing has proven effective at tracing outbreak strains and confirming which cases are part of the same transmission chain.¹⁰

Contact Lens Keratitis and Other Eye Infections

S. marcescens is one of the bacteria linked to corneal infections in contact lens wearers, and though these cases are uncommon, they can threaten vision. The organism has been found in contaminated lens solutions and can adhere to hydrogel lenses. Its ability to stick to a lens increases when the lens has a lower water content.¹¹ Modern multi-purpose solutions containing polyhexamethylene biguanide kill S. marcescens rapidly, but older formulations with polyquaternium have allowed reduced populations to survive for up to 72 hours.

A case report illustrates the clinical course: a 22-year-old woman developed sudden eye symptoms two days after wearing contact lenses, presenting with a corneal abscess and significant inflammation. Initial antibiotic drops failed, and treatment had to be escalated to fortified intravenous-grade eye drops before cultures confirmed S. marcescens and therapy could be streamlined. Her vision ultimately recovered to 20/20 with minimal scarring.¹² The takeaway for lens wearers is straightforward: replace solution daily, never top off old solution, clean the lens case regularly, and avoid sleeping in lenses that are not designed for overnight wear.

How Dangerous Are Bloodstream Infections

When S. marcescens enters the bloodstream, the stakes are high. In one study of 98 adult episodes of S. marcescens bacteremia, 28-day mortality was about 22%. The strongest predictors of death were low blood protein levels and higher organ-failure scores at the time of diagnosis.¹³ In children, the outlook can be grimmer: one pediatric series found overall mortality above 30%, with antimicrobial resistance further complicating treatment.¹⁴ A long-term survey of adult bloodstream infections found that roughly 72% of patients were 60 or older, with high rates of multiple underlying conditions. Among the sickest subgroup, nearly three-quarters died within a month.¹⁵

These mortality figures reflect populations that are already critically ill. For the general public, S. marcescens bacteremia is rare. But the numbers underscore why hospital infection control matters so much: once this organism reaches the bloodstream of a frail patient, the consequences can be severe.

The Growing Problem of Antibiotic Resistance

S. marcescens is intrinsically resistant to several first-line antibiotics. It carries a built-in enzyme called AmpC, a type of beta-lactamase that inactivates many penicillins and older cephalosporins. When AmpC production ramps up and combines with the loss of certain outer membrane channels, even carbapenems, often considered last-resort drugs, can stop working.¹⁶ On top of this baseline resistance, S. marcescens readily acquires additional resistance genes from other bacteria through mobile genetic elements. Resistance to beta-lactam antibiotics is the most common pattern, including resistance to carbapenems, driven by genes such as blaOXA-48 and blaTEM-1 circulating on transferable plasmids.¹⁷

This layered resistance, innate enzymes combined with acquired genes, makes S. marcescens infections harder to treat than many common bacterial infections. Clinicians typically cannot rely on broad-spectrum empirical antibiotics and instead need culture results and susceptibility testing to select effective drugs. In the community-acquired IV drug user population mentioned earlier, over a third of isolates showed possible or confirmed extended-spectrum beta-lactamase production.⁶

How Hospitals Track and Stop Outbreaks

Standard surveillance involves culturing suspect isolates and comparing them. MALDI-TOF mass spectrometry, a rapid identification technology now standard in many hospital labs, can cluster S. marcescens isolates with roughly 90% agreement with genomic typing, offering a faster preliminary screen during outbreaks.¹⁸ Whole-genome sequencing provides the definitive picture, confirming whether patient isolates match environmental ones.

Tracing the source often leads to mundane-sounding culprits. One ICU outbreak was traced to a contaminated soap dispenser; after it was removed, no further cases occurred.¹⁹ ICU sinks are another persistent reservoir, harboring bacterial populations that serve as ongoing sources of both S. marcescens and the resistance genes it carries.²⁰ One Hungarian ICU outbreak was tied to a disinfectant-resistant strain, and control required switching to a different disinfectant product along with tightened cleaning and hand hygiene protocols.²¹

Eliminating the bacterium from sink drains is surprisingly difficult. A NICU study tested several approaches and found that chlorine-based disinfection was ineffective. Thermal methods like boiling water and steam treatments initially killed bacteria across four to eight orders of magnitude, but in drains with well-established biofilms, clonal strains of S. marcescens recolonized after heat treatment.²² This recolonization problem is one reason that some hospitals have redesigned plumbing in high-risk wards rather than relying on repeated disinfection cycles.

Prevention at Home

The pink slime in your bathroom is almost certainly S. marcescens thriving on soap residue and moisture. It is generally harmless to healthy people, though it should not be ignored in homes where someone is immunocompromised, has open wounds, or uses a catheter. Practical steps to reduce it include wiping down wet surfaces after bathing, improving bathroom ventilation to reduce humidity, cleaning with a bleach-based product weekly, and not leaving stagnant water in sinks or pet bowls for extended periods. The organism feeds on fatty acids in soap and shampoo residue, so rinsing surfaces well after use removes its food source.

Contact lens hygiene deserves a separate mention because the eye is particularly vulnerable to S. marcescens. Using fresh solution each time, replacing the lens case every one to three months, and washing hands before handling lenses are simple habits that substantially reduce risk.

Phage Therapy and Emerging Alternatives

With antibiotic resistance rising, researchers are investigating bacteriophages, viruses that specifically infect and kill bacteria, as an alternative or complement to drugs. Several phages targeting S. marcescens have been isolated and characterized in recent years. One phage called BUCT805, isolated from wastewater, effectively killed S. marcescens and showed significant biofilm-destroying activity at high concentrations against all strains tested.²³ Another phage, Spe5P4, was studied for potential use in lung infections caused by multidrug-resistant S. marcescens. Genome analysis confirmed it carried no virulence or antibiotic-resistance genes, an important safety criterion for clinical application.²⁴

Phage research is also expanding beyond the hospital. A phage isolated from river water in South Africa, named WR01, showed strong ability to both prevent new biofilm formation and disrupt mature biofilms of S. marcescens originally found on tomatoes, pointing toward food-safety applications.²⁵ A biosurfactant derived from Lactobacillus acidophilus has also been shown to dramatically reduce S. marcescens biofilm attachment in lab settings, suggesting that probiotic-derived compounds might one day complement conventional cleaning strategies.²⁶ None of these approaches has reached routine clinical use yet, but the pace of phage research against this organism has accelerated considerably.

Prodigiosin as a Potential Drug

Prodigiosin, the red pigment, is not just a curiosity. It has attracted interest as a potential anticancer, antimicrobial, and immunomodulatory compound.³ Laboratory studies have shown it has antibacterial activity against both Gram-positive and Gram-negative species, with minimum inhibitory concentrations as low as about 4 micrograms per milliliter against some organisms. At 100 micrograms per milliliter it showed no harmful effects on normal skin cells and even promoted mild wound healing in cell culture experiments.²⁷ These are lab findings, not clinical results, but they explain why prodigiosin remains an active area of pharmaceutical research. Interestingly, S. marcescens ramps up prodigiosin production when under viral attack: infection with the Chi phage at certain growth phases led to a 5.5-fold increase in pigment output.²⁸

An Ecological Generalist With Surprising Reach

S. marcescens is not just a hospital pathogen. It occupies an astonishing range of ecological niches. Its genome is flexible enough to infect humans, insects, plants, and even marine invertebrates, with different subsets of genes tailored to each host type. Strains that target insects carry hydrolases and potentially neurotoxic enzymes, while plant-associated strains use secretion systems that manipulate plant cell walls and may even promote plant growth by releasing nutrients.²⁹

In agriculture, certain S. marcescens strains are being explored as biological pest control agents. One strain (S-JS1) colonized rice roots and shoots after seed inoculation and boosted seed germination by 9–13%, root length by 8–36%, and shoot length by 4–22%. Treated plants also repelled rice planthoppers: adult insects preferred untreated plants in choice tests, and nymph survival dropped on inoculated plants.³⁰ The mechanisms of S. marcescens in pest management, including metabolite production and triggering plant defense pathways, have generated enough research for dedicated reviews on its potential role in sustainable agriculture.³¹

When Human Sewage Kills Coral

Perhaps the most unexpected chapter in the S. marcescens story involves coral. In the early 2000s, researchers identified it as the cause of white pox disease, which was devastating populations of elkhorn coral in the Florida Keys, with losses of living coral cover typically exceeding 70%.³² It was the first documented case of a human-associated gut bacterium causing disease in a marine invertebrate. A specific strain, PDR60, was found in both human sewage and diseased coral tissue, as well as in predatory snails and nearby reef water, supporting a sewage-to-reef transmission route.³³

Later systematic surveys found S. marcescens in roughly 27% of white pox lesions and in mucus from apparently healthy colonies about 9% of the time. The pathogenic PDR60 strain was still circulating on reefs, though it did not appear to be the primary driver in more recent disease episodes, suggesting other pathogens or environmental stressors may now contribute to the symptoms of white pox.³⁴ The story serves as a stark reminder of how wastewater management on land can have cascading effects in ocean ecosystems, and how a single bacterial species can cross dramatically different biological kingdoms.